Three New CeraVe® Baby Products Awarded National Eczema Association (NEA) Seal of Acceptance™
BRIDGEWATER, N.J., March 12, 2015 /PRNewswire/ -- Valeant Pharmaceuticals North America LLC is pleased to announce today that all three products in its newest product line, CeraVe® Baby, have been awarded the National Eczema Association (NEA) Seal of Acceptance™, which maintains rigorous standards for approval. Products include CeraVe® Baby Wash & Shampoo, CeraVe® Baby Moisturizing Lotion, and CeraVe® Baby Diaper Rash Cream. Free of fragrance, parabens, and sulfates, this three-step skincare regimen was developed with pediatric dermatologists to help protect and maintain baby's delicate skin barrier.
The National Eczema Association, a patient-oriented organization guided by physicians and scientists, is dedicated to improving the quality of life for people who suffer from eczema and sensitive skin. The NEA Seal further helps these individuals to make informed purchasing decisions and recognize skincare products that are suitable for eczema or sensitive-skin.
John Reed, Senior Brand Manager for Valeant, stated, "We are honored that these CeraVe® Baby products were awarded the NEA Seal of Acceptance™ and we strongly support the National Eczema Association in its mission to help parents make informed decisions when caring for their baby."
Products eligible for the NEA Seal of Acceptance™ are those that have been created or intended for use by people with eczema or severe sensitive skin conditions and that have satisfied the NEA Seal of Acceptance™ criteria. The Seal of Acceptance™ criteria include review of testing results on sensitivity, safety and toxicity, as well as ingredient and formulation data.
With the inclusion of these three products, 11 CeraVe® products have been awarded the NEA Seal of Acceptance™. Plans to feature the NEA Seal on product packaging are currently in-the-works. The CeraVe® Baby Line is available at Walmart, Walgreens, CVS and specialty baby retailers nationwide and each product has a Suggested Retail Price of $9.99. For more information, please visit: http://www.cerave.com or www.valeant.com.
About Valeant Pharmaceuticals North America LLC:
Valeant Pharmaceuticals North America LLC, is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, consumer healthcare and other pharmaceutical products. More information about Valeant Pharmaceuticals can be found at www.valeant.com.
About National Eczema Association:
The National Eczema Association (NEA) is a non-profit 501(c)(3) organization whose mission is to improve the health and quality of life for individuals with atopic dermatitis/eczema through research, support, and education. The National Eczema Association (NEA) was founded in 1988. NEA is governed by a Board of Directors and guided by a Scientific Advisory Committee comprised of physicians and scientists who donate their time and expertise. NEA is entirely supported through individual and corporate contributions.
CeraVe® is a registered trademark of Valeant Pharmaceuticals International, Inc. or its affiliates. All other trademarks are the property of their respective owners. ©2015 Valeant Pharmaceuticals North America LLC.
MEDIA CONTACT:
Anneka Ranpuria
The Lane Communications Group
212.757.6880
[email protected]
Photo - http://photos.prnewswire.com/prnh/20150310/180753
SOURCE Valeant Pharmaceuticals North America LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article